【 SUIBE思源金融论坛——学术报告第53期 】:Opioid Epidemic and Corporate Innovation

pubdate:2022-12-11views:292

报告人:施畅

时间:202212月13日 13:30

腾讯会议号:624 477 816

会议密码:258963


【报告人简介】

施畅,上海对外经贸大学金融管理学院讲师,金融学博士,20226月毕业于香港城市大学经济金融系。主要研究领域为实证公司金融,包括企业人力资本、企业创新、M&As等领域。曾受邀参加2022 Asian Finance Association Annual Meeting , 2022 Financial Markets and Corporate Governance等金融学领域国际会议并报告论文。


【内容摘要】

This paper examines the impact of the local opioid epidemic on corporate innovation. Using a large sample of U.S. public firms from 2003 to 2017, we find that firms located in counties with higher death rates caused by opioid overdoses are significantly less innovative as measured by their patenting activities. To establish causality, we exploit the state implementations of the Prescription Drug Monitoring Programs (PDMPs) as quasi-experiments and an instrumented variable approach. We find suggestive evidence that the opioid epidemic hinders local firms’ innovation by increasing their healthcare costs, decreasing their productivity, and by causing an exodus of local inventors.


【主持人简介】

应尚军,教授,资产评估师,上海对外经贸大学金融管理学院副院长、资产评估研究所所长、硕士生导师。兼任全国资产评估教育研究会共同会长、中国优选法统筹法与经济数学研究会能源经济与管理研究分会常务理事、上海市金融学会理事、上海市金融硕士教学指导委员会成员、上海市国资系统资产评估评审专家。





Baidu
map